Vanguard disaggregates holdings; reports 0 shares in Dorman (NASDAQ: DORM)
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 12 to a Schedule 13G/A reporting beneficial ownership of 0 shares of Dorman Products Inc common stock. The filing states Vanguard completed an internal realignment on January 12, 2026 under SEC Release No. 34-39538, resulting in certain subsidiaries reporting beneficial ownership separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Amendment reflects administrative disaggregation under SEC Release No. 34-39538.
The filing documents that Vanguard's internal realignment caused certain subsidiaries to report holdings separately, and as a result Vanguard reports 0 shares beneficially owned in Dorman Products Inc. The text cites SEC Release No. 34-39538 and the January 12, 2026 realignment.
From a compliance perspective, this is a routine disclosure correcting beneficial-ownership reporting lines; timing and formality are shown by the 03/26/2026 signature date.
Operational change, not an economic trade signal; holdings are reported at the subsidiary level now.
The amendment states Vanguard no longer is deemed to beneficially own the securities held by certain subsidiaries; it therefore reports 0 shares for the parent entity. The filing clarifies that subsidiaries pursue the same investment strategies as before.
Investor interpretation: the entry signals a reporting shift rather than a disposition of shares; subsequent filings from the named subsidiaries will show actual holdings.
FAQ
What does the Schedule 13G/A filed by Vanguard say about DORM holdings?
Why does Vanguard report 0 shares for DORM after the amendment?
When did Vanguard's realignment that triggered the amendment occur?
Who signed the Schedule 13G/A amendment for Vanguard?
Does this amendment mean Vanguard sold its DORM shares?